Lumida
/KRRO
⌘K
Korro Bio Inc

Korro Bio Inc

KRRO
$13.81USD+5.74%+0.75 today

MARKET CAP

203.4M

P/E (TTM)

FWD P/E

DAY RANGE

$13 – $14

52W RANGE

$5
$56

AI Summary

Stalk
Buy NowMedium

KRRO has carved a Stage 1 base after a steep capitulation, enabling mean-reversion entries. The medium-term bias is bullish under mean-reversion eligibility and defined support. Recently, price has held a pullback into the rising 9/21/50-day EMA zone and prior consolidation highs, showing no short-term exhaustion. This presents a favorable entry on a supportive interaction. A breakdown below the EMA confluence and base support would invalidate this bullish posture.

  • HC Wainwright reiterates Buy rating with $15 price target.
  • CoinCodex projects 27.6% upside to $16.46 by end-2026.
  • Profitability metrics remain weak, reflecting poor return generation.
Full analysis →
Insider Trades9 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 4, 2026SellKRRORam AiyarPresident and CEO5,802$10.84$203.4M-75.29%+165.35%$62.9K-7.75%Buy Now
Jun 16, 2026SellKRROTodd ChappellChief Operating Officer3,168$10.83$203.4M-75.29%+165.35%$34.3K-15.74%Buy Now
Jun 16, 2026SellKRROOliver DolanSenior Vice President, Finance3,383$10.83$203.4M-75.29%+165.35%$36.6K-15.75%Buy Now
Jun 16, 2026SellKRROLoic A VincentChief Scientific Officer3,418$10.83$203.4M-75.29%+165.35%$37.0K-15.74%Buy Now
Jun 16, 2026SellKRROJeffrey CerioGeneral Counsel6,609$10.83$203.4M-75.29%+165.35%$71.6K-15.77%Buy Now
May 29, 2026SellKRRORam AiyarPresident and CEO15,152$12.98$203.4M-75.29%+165.35%$196.7K-16.84%Buy Now
May 26, 2026BuyKRRORam AiyarPresident and CEO50,000$12.33$203.4M-75.29%+165.35%$616.5K+125.00%Buy Now
Nov 11, 2024SellKRROVineet AgarwalChief Financial Officer1,600$40.84$203.4M-75.29%+165.35%$65.3K+0.00%10b5-1Buy Now
Oct 17, 2024SellKRROVineet AgarwalChief Financial Officer20,432$45.13$203.4M-75.29%+165.35%$922.0K+0.00%10b5-1Buy Now